Exchange: NASDAQ·Updated 07:00 AM EDT
CAMP logo

CAMP Calamp Corp.

$3.47
$0.08
(2.36%)
Pre-Market
Prev Close $3.39
Reported EarningsAug 13
Mkt Cap$212.73M
Vol5,420.00

About CAMP

CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
54

Neutral Sentiment

How do you feel about CAMP?

focafoca99
$CAMP hosted an Analyst Day, detailing its ASCEND Phase 1/2 trial in SYNGAP1 disorder and pipeline progress.
1

Advertisement|Remove ads.